Search Results - "Smith, B.Douglas"

Detection of FLT3 Internal Tandem Duplication and D835 Mutations by a Multiplex Polymerase Chain Reaction and Capillary Electrophoresis Assay by Murphy, Kathleen M., Levis, Mark, Hafez, Michael J., Geiger, Tanya, Cooper, Lisa C., Smith, B.Douglas, Small, Donald, Berg, Karin D.

“…FLT3 is a receptor tyrosine kinase that is expressed on early hematopoietic progenitor cells and plays an important role in stem cell survival and…”
Get full text

Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide by Kanakry, Christopher G., Bolaños-Meade, Javier, Kasamon, Yvette L., Zahurak, Marianna, Durakovic, Nadira, Furlong, Terry, Mielcarek, Marco, Medeot, Marta, Gojo, Ivana, Smith, B.Douglas, Kanakry, Jennifer A., Borrello, Ivan M., Brodsky, Robert A., Gladstone, Douglas E., Huff, Carol Ann, Matsui, William H., Swinnen, Lode J., Cooke, Kenneth R., Ambinder, Richard F., Fuchs, Ephraim J., de Lima, Marcos J., Andersson, Borje S., Varadhan, Ravi, O'Donnell, Paul V., Jones, Richard J., Luznik, Leo

“…The intensive and prolonged immunosuppressive therapy required to prevent or treat graft-versus-host disease (GVHD) after allogeneic blood or marrow…”
Get full text

Poly(ADP-ribose) Polymerase Inhibitors Sensitize Cancer Cells to Death Receptor-mediated Apoptosis by Enhancing Death Receptor Expression by Meng, X.Wei, Koh, Brian D., Zhang, Jin-San, Flatten, Karen S., Schneider, Paula A., Billadeau, Daniel D., Hess, Allan D., Smith, B.Douglas, Karp, Judith E., Kaufmann, Scott H.

“…Recombinant human tumor necrosis factor-α-related apoptosis inducing ligand (TRAIL), agonistic monoclonal antibodies to TRAIL receptors, and small molecule…”
Get full text

4EBP1/c-MYC/PUMA and NF-κB/EGR1/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells by Yun, Seongseok, Vincelette, Nicole D., Knorr, Katherine L.B., Almada, Luciana L., Schneider, Paula A., Peterson, Kevin L., Flatten, Karen S., Dai, Haiming, Pratz, Keith W., Hess, Allan D., Smith, B.Douglas, Karp, Judith E., Hendrickson, Andrea E.Wahner, Fernandez-Zapico, Martin E., Kaufmann, Scott H.

“…The mammalian target of rapamycin (mTOR), a kinase that regulates proliferation and apoptosis, has been extensively evaluated as a therapeutic target in…”
Get full text

Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia by Rondelli, Damiano, Barosi, Giovanni, Bacigalupo, Andrea, Prchal, Josef T., Popat, Uday, Alessandrino, Emilio P., Spivak, Jerry L., Smith, B.Douglas, Klingemann, Hans G., Fruchtman, Steven, Hoffman, Ronald

“…A total of 21 patients with myelofibrosis with myeloid metaplasia (MMM), with a median age of 54 years (range, 27-68 years), were prepared with a…”
Get full text

Ribonucleotide reductase: an old target with new potential by Smith, B.Douglas, Karp, Judith E.

Get full text

Philadelphia chromosome-negative engraftment after autologous transplantation with granulocyte-macrophage colony-stimulating factor for chronic myeloid leukemia by Gladstone, Douglas E., Bedi, Atul, Miller, Carole B., Noga, Stephen J., Griffin, Constance A., Piantadosi, Steven, Cagnoni, Pablo J., Brodsky, Robert A., Smith, B.Douglas, Douglas, Tracy T., Shpall, Elizabeth J., Jones, Richard J.

“…Autologous bone marrow transplantation (BMT) has not been curative in chronic myeloid leukemia (CML), because of the inability to purge CML from the autograft…”
Get full text